Press release
Artificial Intelligence In Genomics Market by Drivers, Restraints, Opportunities, and Challenges | Ibm, Microsoft, Nvidia Corporation
“AI in genomics market to register a CAGR of 52.7% from 2020 to 2025”ReportsnReports added Artificial Intelligence In Genomics Market Research Report created by Report Consultant, which offers detailed insights, revenue details, and other information regarding the global market, and the various trends, drivers, restraints, opportunities, and market till 2028. Artificial Intelligence In Genomics Market Report offers detailed information regarding the leading key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions and mergers, and market footprint. Artificial Intelligence In Genomics Market also provides a comparative analysis of the market dynamics pre and post Covid19 outbreak.
Request for FREE PDF Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4235597
Top Company Profile Analysis in this Report- IBM (US), Microsoft (US), NVIDIA Corporation (US), Deep Genomics (Canada), BenevolentAI (UK), Fabric Genomics Inc. (US), Verge Genomics (US), Freenome Holdings, Inc. (US), MolecularMatch Inc. (US), Cambridge Cancer Genomics (UK), SOPHiA GENETICS (US), Data4Cure Inc. (US), PrecisionLife Ltd (UK), Genoox Ltd. (US), Lifebit (UK), Diploid (Belgium), FDNA Inc. (US), DNAnexus Inc. (US), Empiric Logic (Ireland), and Engine Biosciences Pte. Ltd. (US).
The global AI in genomics market is projected to reach USD 1,671 million by 2025 from USD 202 million in 2020, at a CAGR of 52.7% between 2020 and 2025. The need to control drug development and discovery costs and time, increasing public and private investments in AI in genomics, and the adoption of AI solutions in precision medicine are driving the growth of this market. However, the lack of a skilled AI workforce and ambiguous regulatory guidelines for medical software are expected to restrain the market growth during the forecast period.
In 2019, North America accounted for the largest share of the AI in genomics market, followed byEurope. The large share of North America can be attributed to the increasing research funding and government initiatives for promoting precision medicine in the US. The market in the Asia Pacific region, on the other hand, is projected to register the highest CAGR during the forecast period. Emerging countries in the APAC, such as India and China, offer lucrative growth opportunities for market players, primarily due to the increasing public and private funding, improving healthcare infrastructure, and rapideconomic growth.
Reasons to Buy the Report:
The report provides insights on the following pointers:-
Market Penetration: Comprehensive information on the AI in genomics offered by the key 20 players in the AI in genomics market. The report analyzes the AI in genomics market by offering, technology, functionality, application, end user, and region.
Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various AI in genomics, their adoption, and usage across key geographic regions.
Market Diversification: Exhaustive information about new product launches, untapped geographies, recent developments, and investments in the AI in genomics market
Competitive Assessment: In-depth assessment of market ranking and strategies of the leading players in the AI in genomics market.
Single User License: US $ 5650
Get FLAT 25% Discount on this Report @ https://www.reportsnreports.com/purchase.aspx?name=4235597
Table Of Contents in this Report-
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.2.1 Inclusions And Exclusions
1.3 Market Scope
1.3.1 Markets Covered
Figure 1 Artificial Intelligence In Genomics: Market Segmentation
1.3.2 Years Considered For The Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology
2.1 Research Data
Figure 2 Research Design
2.2 Secondary Sources
2.2.1 Key Data From Secondary Sources
2.3 Primary Data
2.3.1 Primary Sources
2.3.2 Breakdown Of Primary Interviews
Figure 3 Breakdown Of Primary Interviews: By Demand Side, Supply Side, Designation, And Region
2.3.2.1 Key Industry Insights
2.4 Market Size Estimation
Figure 1 Bottom-Up Approach
Figure 2 Top-Down Approach
Figure 3 Estimation Of The Ai In Genomics Market Size Through The Adoption-Based Approach
Table 1 Factor Analysis
2.5 Market Breakdown And Data Triangulation
Figure 4 Data Triangulation Methodology
2.6 Assumptions For The Study
3 Executive Summary
Figure 5 Ai In Genomics Market, By Offering, 2020 Vs. 2025 (Usd Million)
Figure 6 Ai In Genomics Market, By Technology, 2020 Vs. 2025 (Usd Million)
Figure 7 Ai In Genomics Market, By Functionality, 2020 Vs. 2025 (Usd Million)
Figure 8 Ai In Genomics Market, By Application, 2020 Vs. 2025 (Usd Million)
Figure 9 Ai In Genomics Market, By End User, 2020 Vs. 2025 (Usd Million)
Figure 10 Geographical Snapshot Of The Ai In Genomics Market
4 Premium Insights
4.1 Ai In Genomics: Market Overview
Figure 11 Increasing Public And Private Investments In Ai In Genomics And Adoption Of Ai Solutions For Precision Medicine Are Driving Market Growth
4.2 Ai In Genomics Market, By End User
Figure 12 Providers Accounted For The Largest Share Of The Market In 2019
4.3 North America: Ai In Genomics Market, By Technology & Country (2019)
Figure 13 Us Accounted For The Largest Share Of The North American Market In 2019
4.4 Geographical Snapshot Of The Ai In Genomics Market
Figure 14 Asia Pacific To Register The Highest Growth Rate During The Forecast Period
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Need To Control The Time And Costs Of Drug Development And Discovery
5.2.1.2 Increasing Investments In Ai In Genomics
5.2.1.3 Rising Adoption Of Ai In Precision Medicine
5.2.1.4 Growing Genomic Datasets
5.2.2 Restraints
5.2.2.1 Lack Of Skilled Ai Workforce And Ambiguous Regulatory Guidelines For Medical Software
5.2.3 Opportunities
5.2.3.1 Focus On Developing Human-Aware Ai Systems
5.2.4 Challenges
5.2.4.1 Lack Of Curated Genomic Data
5.2.4.2 Data Privacy Concerns
5.3 Impact Of Covid-19 On The Ai In Genomics Market
Figure 15 Impact Of Covid-19 On The Ai In Genomics Market
5.4 Ecosystem
Figure 16 Ai In Genomics Market: Ecosystem
6 Artificial Intelligence In Genomics Market, By Offering
6.1 Introduction
Table 2 Artificial Intelligence In Genomics Market, By Offering, 2018–2025 (Usd Million)
6.2 Software
6.2.1 Benefits Offered By Software & Strong Demand Among End Users Are Driving Market Growth
Table 3 Ai In Genomics Market For Software, By Region, 2018–2025 (Usd Million)
Table 4 North America: Ai In Genomics Market For Software, By Country, 2018–2025 (Usd Million)
Table 5 Europe: Ai In Genomics Market For Software, By Country, 2018–2025 (Usd Million)
6.3 Services
6.3.1 Services Segment To Witness The Highest Growth During The Forecast Period
Table 6 Ai In Genomics Market For Services, By Region, 2018–2025 (Usd Million)
Table 7 North America: Ai In Genomics Market For Services, By Country, 2018–2025 (Usd Million)
Table 8 Europe: Ai In Genomics Market For Services, By Country, 2018–2025 (Usd Million)
7 Artificial Intelligence In Genomics Market, By Technology
and more...
Corporate Headquarters
Tower B5, office 101,
Magarpatta SEZ,
Hadapsar, Pune-411013, India
+ 1 888 391 5441
sales@reportsandreports.com
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Artificial Intelligence In Genomics Market by Drivers, Restraints, Opportunities, and Challenges | Ibm, Microsoft, Nvidia Corporation here
News-ID: 2277898 • Views: …
More Releases from ReportsnReports

DeviceCon Series 2024 - UK Edition | MarketsandMarkets
Future Forward: Redefining Healthcare with Cutting-Edge Devices
Welcome to DeviceCon Series 2024 - Where Innovation Meets Impact!
Join us on March 21-22 at Millennium Gloucester Hotel, 4-18 Harrington Gardens, London SW7 4LH for a groundbreaking convergence of knowledge, ideas, and technology. MarketsandMarkets proudly presents the DeviceCon Series, an extraordinary blend of four conferences that promise to redefine the landscape of innovation in medical and diagnostic devices.
Register Now @ https://events.marketsandmarkets.com/devicecon-series-uk-edition-2024/register
MarketsandMarkets presents…

5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Confer …
London, March 7, 2024 - MarketsandMarkets is thrilled to announce the eagerly awaited 5th Annual Infectious Disease and Molecular Diagnostics Conference, scheduled to take place on March 21st - 22nd, 2024, at the prestigious Millennium Gloucester Hotel, located at 4-18 Harrington Gardens, London SW7 4LH.
This conference promises to be a groundbreaking event, showcasing the latest trends and insights in diagnosis, as well as unveiling cutting-edge technologies that are revolutionizing the…

Infection Control, Sterilization & Decontamination Conference |21st - 22nd March …
MarketsandMarkets is pleased to announce its 8th Annual Infection Control, Sterilisation, and Decontamination in Healthcare Conference, which will take place March 21-22, 2024, in London, UK. With the increased risk of infection due to improper sterilisation and decontamination practices, the safety of patients and healthcare workers is of paramount importance nowadays.
Enquire Now @ https://events.marketsandmarkets.com/infection-control-sterilization-and-decontamination-conference/
This conference aims to bring together all the stakeholders to discuss the obstacles in achieving…

Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, S …
The global Breast Augmentation Market in terms of revenue was estimated to be worth $900 million in 2020 and is poised to reach $1,692 million by 2025, growing at a CAGR of 13.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying…
More Releases for Genomic
Emerging Trends Influencing The Growth Of The Genomic Biomarker Market: Technolo …
The Genomic Biomarker Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
How Big Is the Genomic Biomarker Market Size Expected to Be by 2034?
The size of the genomic biomarker market has witnessed swift expansion in the recent past. It is slated to expand from a…
Top Factor Driving Genomic Biomarker Market Growth in 2025: Impact of Chronic Di …
How Big Is the Genomic Biomarker Market Expected to Be, and What Will Its Growth Rate Be?
The size of the genomic biomarker market has seen a swift expansion in recent times. It's expected to increase from $8.4 billion in 2024 to $9.9 billion in 2025, growing at a compound annual growth rate (CAGR) of 18.0%. The historic period growth can be credited to the growing awareness about genetic disorders, heightened…
Genomic Biomarker Market Future Business Opportunities 2025-2032 | Liquid Genomi …
Latest Report, titled "Genomic Biomarker Market" Trends, Share, Size, Growth, Opportunity and Forecast 2025-2032, by Coherent Market Insights offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
The report features a comprehensive table of contents, figures, tables, and charts, as well as insightful analysis. The Genomic Biomarker market has been expanding significantly…
Lipid-Nanoparticle Based Genomic Medicines Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Lipid-Nanoparticle Based Genomic Medicines Market - (By Type (Liposome-based Nanoparticles, Micelle-based Nanoparticles, Lipid-Coated Nanoparticles), By Application (Cancer Treatment, Infectious Diseases, Genetic Disorders, Cardiovascular Diseases, Others), By Therapeutic Payload (mRNA-based Therapeutics, siRNA-based Therapeutics, miRNA-based Therapeutics, Other Genomic Medicines), By End-User (Hospitals, Biopharmaceutical Companies, Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the…
Genomic Biomarkers Market 2022 | Detailed Report
The research reports on “Genomic Biomarkers Market” report gives detailed overview of factors that affect global business scope. Genomic Biomarkers Market report shows the latest market insights with upcoming trends and breakdowns of products and services. This report provides statistics on the market situation, size, regions and growth factors. An exclusive data offered in this report is collected by research and industry experts team.
Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5334064
The…
Latest Survey on Genomic Medicine Market 2019 by Key Companies Overview-BioMed C …
The recently published report called “Global Genomic Medicine Market 2019” offers a brief overview of the Genomic Medicine market across the globe. The research report showcases innovative tool for evaluating the complete scenario of the Genomic Medicine market with its tactical decision making, opportunities and supporting strategic. Furthermore, the report also analyses the competitive analysis as well as changing trends which becomes most crucial in order to monitor the performance…